Insulin aspart was the second rapidly acting analogue introduced, approved for clinical use in Europe in 1999 and by the FDA in 2000 for patients with Type 1 or Type 2 diabetes.

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys insulin-producing beta cells. Without these cells, blood glucose control becomes a ...

More than 8 million people worldwide live with type 1 diabetes, a lifelong condition marked by the loss of insulin-producing beta cells.

A woman says she's living in "constant fear and worry" about getting enough insulin, amid a global shortage of certain types of the medicine. Dee Parker was diagnosed with Type 1 Diabetes when she ...

Results Of the 189 medications listed in AHFS Drug Information 2006 for storage in a refrigerator, [9] 89 were present in our pharmacy department's refrigerator and were included in this review ...

Trying to solve the Wordle today? If you're stuck, we've got a few hints that will help you keep your Wordle streak alive.

Insulin pumps are small, wearable devices that deliver rapid-acting insulin for people with diabetes. Learn how they work, their benefits, their drawbacks, and more.

The American College of Physicians (ACP) issued new A1C guidelines for people managing type 2 diabetes, drawing both criticism and praise. Here’s what to know about the new target range and what ...

When it comes to saving the planet, one whale is worth thousands of trees. Scientific research now indicates more clearly than ever that our carbon footprint—the release of carbon dioxide (CO 2) into ...